EQT Life Sciences participates in RQ Bio's USD 115 million Series A financing

STOCKHOLM, June 24, 2026 /PRNewswire/ -- EQT Life Sciences joins new investors Frazier Life Sciences, Forbion, Monograph and Wellington Management, alongside existing investors LifeArc, Oxford Science Enterprises and Oxford University Innovation, in RQ Bio's oversubscribed USD 115 million...